U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Previous Screen

Trimethobenzamide Hydrochloride Capsules
Status: Currently in Shortage
»Date first posted: 02/16/2021
»Therapeutic Categories: Gastroenterology

Expand all

Lupin (Reverified 10/25/2021)

Company Contact Information:
866-587-4617

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
300 mg, bottle of 30 (NDC 43386-660-03) Currently unavailable. Estimated shortage duration: TBD Shortage of an active ingredient.
300 mg, bottle of 100 (NDC 43386-660-24) Currently unavailable. Estimated shortage duration: TBD Shortage of an active ingredient.
300 mg, bottle of 500 (NDC 43386-660-26) Currently unavailable. Estimated shortage duration: TBD Shortage of an active ingredient.

Pfizer Pharmaceuticals (Reverified 07/01/2022)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
300 mg, bottle of 100 (NDC 61570-079-01) Discontinued

Link to Discontinuance

Discontinuation of the manufacture of the drug.

Sun Pharmaceutical Industries Inc. (Revised 10/26/2021)

Company Contact Information:
800-810-4555

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
300 mg, bottle of 100 (NDC 53489-376-01) Unavailable

Link to Discontinuance

Shortage of an active ingredient.
Back to Top